Form 8-K - Current report:
SEC Accession No. 0001387131-19-009918
Filing Date
2019-12-30
Accepted
2019-12-30 07:02:50
Documents
14
Period of Report
2019-12-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT txmd-8k_122719.htm   iXBRL 8-K 41012
2 PRESS RELEASE FROM THERAPEUTICSMD, INC., DATED DECEMBER 30, 2019 ex99-1.htm EX-99.1 13989
6 GRAPHIC ex99-1_001.jpg GRAPHIC 3285
  Complete submission text file 0001387131-19-009918.txt   240995

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT txmd-20191227.xsd EX-101.SCH 3204
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT txmd-20191227_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT txmd-20191227_pre.xml EX-101.PRE 22722
11 EXTRACTED XBRL INSTANCE DOCUMENT txmd-8k_122719_htm.xml XML 3607
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 191314752
SIC: 2834 Pharmaceutical Preparations